Dennis Kim, MD, PhD is a board-certified interventional cardiologist for both pediatric and adult congenital heart patients, and serves as the Director of the Pediatric Cardiac Catheterization Labs at the Children’s Healthcare of Atlanta Heart Center. In addition to providing patient care, Dr. Kim holds an academic appointment, serving as a Professor of Pediatrics at the Emory University School of Medicine to train the next generation of pediatric cardiologists.
Dr. Kim received his medical education at the University of Texas Medical Branch at Galveston and completed his residency in pediatrics at the University of Michigan in Ann Arbor, MI. Dr. Kim completed pediatric cardiology and pediatric interventional cardiology fellowships at the University of Michigan Congenital Heart Center, receiving focused training in advanced cardiac therapies and catheterization techniques. In his role as Director of the Pediatric Cardiac Catheterization Labs, Dr. Kim ensures that the Children’s Heart Center provides the full spectrum of diagnostic and interventional capabilities to deliver the best possible heart care to patients. He is skilled in interventional procedures and minimally invasive treatments for congenital heart disease, such as transcatheter valve replacement and septal defect repair, and is involved in a variety of clinical trials for new transcatheter device therapies.
Focus of Practice
- Transcatheter minimally invasive cardiac therapies
- Interventional catheterization therapies for adults with congenital heart disease
- Procedural radiation exposure reduction
Areas of Interest
- Pediatric interventional cardiac catheterization
- Adult congenital interventional cardiac catheterization
- Cardiac intensive care
Childrens Healthcare of Atlanta Cardiology, Inc.1405 Clifton Rd NE Atlanta, GA 30322 404-256-2593
Childrens Healthcare of Atlanta Cardiology, Inc.3890 Johns Creek Pkwy, Ste 240 Suwanee, GA 30024 404-256-2593
Research & Publications
New transcatheter therapies for congenital heart disease, clinical trials for emerging transcatheter device therapies, interventional outcomes and process improvement